Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACHV · against 483 other Healthcare companies of similar size
Ranked #316 of 484 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score169 peers with a valuation score of 0–9, including ACHV · Click a bar to see the companies
Mainly because of its earnings yield, EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | ACHV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 473 reported | -24.7% | 0.7% | 9% | 30% | |
| EBITDA yieldHigher is better · 489 reported | -11.2% | 3.6% | 17% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -6.8% | -4.1% | 43% | 20% | |
| Book yieldHigher is better · 481 reported | -2.1% | 45.4% | 4% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 316 | 14.9B TWD (≈$462M) | 8 | 42 | |
| 316 | 15.6B TWD (≈$485M) | 8 | 49 | |
| 316 | 13.0B TWD (≈$402M) | 8 | 49 | |
| 316 | 1.3B USD | 8 | 15 | |
| 316 | 693M USD | 8 | ||
| 316 | 551M USD | 8 | 20 | |
| 316 | 831M USD | 8 | ||
| 316 | 387M USD | 8 | 49 | |
| 316 | 841M USD | 8 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score